Search
for
Sort by
Research 91–120 of 1000+
- TRICHOTILLOMANIA WITH GIANT GASTRIC TRICHOBEZOAR IN A FEMALE CHILD: A CASE REPORT
- Hair-Pulling Disorder
- HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?
- Hair Loss Associated with Sertraline: Two Case Reports and Review
- Letters to the Editors
- Antidepressants have Anti-inflammatory Effects that may be Relevant to Dermatology: A Systematic Review
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- Sex Hormones and Related Compounds, Including Hormonal Contraceptives
- Tales of bugs, delusions of parasitosis, and what to do
- Citalopram–induced delusions in an older adult
- Alleviation of alopecia after switching from escitalopram to duloxetine: a case report
- Approaching Erectile Dysfunction in Dermatology Patients
- 11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
- MK-386, an Inhibitor of 5α-Reductase Type 1, Reduces Dihydrotestosterone Concentrations in Serum and Sebum without Affecting Dihydrotestosterone Concentrations in Semen<sup>1</sup>
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Olumiant® (Baricitinib)-A Newly Approved Janus Kinase Inhibitor for the Treatment of Alopecia Areata.
- Novel 5α-Reductase Inhibitors: Synthesis, Structure−Activity Studies, and Pharmacokinetic Profile of Phenoxybenzoylphenyl Acetic Acids
- Repurposing Finasteride and Serotonin Reuptake Inhibitors as Novel Antimicrobials: A Dual-Action Approach to Target Bacterial and Fungal Pathogens
- Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and In Vivo Evidence
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials
- Phosphodiesterase inhibitors used in androgenic alopecia as a possible risk factor for testicular tumor
- 061 Selective inhibition of tyrosine kinase 2 prevents and restores interleukin-12-induced hair follicle immune privilege collapse: a novel approach to alopecia areata therapy?
- CS12192 Reverses Alopecia Areata by Selectively Targeting JAK3/JAK1/TBK1.
- Targeting noncanonical nuclear factor kappa B signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alpha
- 549 Temporary cell cycle arrest in human scalp hair follicles and their epithelial stem cells by ALRN-6924: A novel strategy to selectively protect p53-wildtype cells against paclitaxel-induced alopecia
- Selective inhibition by minoxidil of prostacyclin production by cells in culture
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition